Flamma Selected For 2025 CDMO Leadership Awards Europe
Chignolo D’Isola, Bergamo, Italy – October 21, 2025 – The Flamma Group (“Flamma”), a global, fully integrated company producing and commercializing small molecule Active Pharmaceutical Ingredients (APIs) for the life science industry as well as a preeminent Contract Development and Manufacturing Organization (CDMO) of New Chemical Entities (NCEs) and late stage intermediates for the Innovator Companies, is proud to announce that it has received a 2025 CDMO Leadership Award Europe that will be presented in Frankfurt on October 28, 2025.
Flamma has been recognized as a 2025 CDMO Leadership Awards Europe winner in the Small Molecule API category. Flamma is also a finalist for the Champion Award which will be announced during the rewards ceremony. The Champion Award recognizes the highest-scoring CDMO in each category. You can learn more at:
https://www.cmoleadershipawards.com/2025-cdmola-europe
“The entire Flamma team is truly honored to receive this award. After being honored earlier in the year in the Small Molecule API- Global category, this additional award shows the industry the commitment that Flamma has made to our customers,” noted Kenneth Drew, Ph.D., VP Flamma USA. “The Outsourced Pharma team goes to great lengths to provide a platform that recognizes excellence in the service side of the Biotech and Pharma industry. Flamma will always continue to work at an award winning level regardless. With that said, it is gratifying to be recognized for our efforts.”
“The 2025 CDMO Leadership Awards Europe is a well-deserved recognition to European organizations that have demonstrated excellence in contract development and manufacturing. These awards are the most important in our industry because they are based on the judgement of biopharma sponsors and the value they place in trusted partnerships,” according to Louis Garguilo, Chief Editor, Outsourced Pharma Flamma will proudly accept the awards at the CDMO Leadership Awards Europe Ceremony and Reception on October 28, 2025 at the Steigenberger Frankfurter Hof in Frankfurt.
Download the press release here
